NCT05857891View on ClinicalTrials.gov

The Effect of Erythropoietin on Alveolar Fluid Clearance in Patients With Acute Respiratory Distress Syndrome

NARecruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

May 20, 2023

Primary Completion Date

October 31, 2026

Study Completion Date

March 31, 2027

Conditions
Acute Respiratory Distress Syndrome
Interventions
DRUG

Human erythropoietin injection

Each subject in the test group received 40000iu of human erythropoietin intravenously

DRUG

0.9%NaCl

Each subject in the control group was injected with an equal volume of 0.9%NaCl

Trial Locations (1)

325000

RECRUITING

SAHWenzhouMU, Wenzhou

All Listed Sponsors
lead

Second Affiliated Hospital of Wenzhou Medical University

OTHER